DK3212182T3 - Behandling eller forebyggelse af anæmi i drægtige ikke-humane pattedyr og afkom - Google Patents
Behandling eller forebyggelse af anæmi i drægtige ikke-humane pattedyr og afkom Download PDFInfo
- Publication number
- DK3212182T3 DK3212182T3 DK15787128.6T DK15787128T DK3212182T3 DK 3212182 T3 DK3212182 T3 DK 3212182T3 DK 15787128 T DK15787128 T DK 15787128T DK 3212182 T3 DK3212182 T3 DK 3212182T3
- Authority
- DK
- Denmark
- Prior art keywords
- anhemia
- procedures
- prevention
- treatment
- human mammals
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/295—Iron group metal compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/721—Dextrans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA201470654 | 2014-10-27 | ||
| PCT/DK2015/050328 WO2016066172A1 (en) | 2014-10-27 | 2015-10-27 | Treatment or prevention of anaemia in pregnant non-human mammals |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3212182T3 true DK3212182T3 (da) | 2019-08-05 |
Family
ID=54360839
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK15787128.6T DK3212182T3 (da) | 2014-10-27 | 2015-10-27 | Behandling eller forebyggelse af anæmi i drægtige ikke-humane pattedyr og afkom |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US11040059B2 (da) |
| EP (2) | EP3603632A1 (da) |
| JP (1) | JP6680777B2 (da) |
| CN (3) | CN113559115A (da) |
| BR (1) | BR112017008709A2 (da) |
| CA (1) | CA2965722C (da) |
| DK (1) | DK3212182T3 (da) |
| ES (1) | ES2743223T3 (da) |
| HU (1) | HUE045092T2 (da) |
| LT (1) | LT3212182T (da) |
| MX (1) | MX2017005419A (da) |
| PH (1) | PH12017500646A1 (da) |
| PL (1) | PL3212182T3 (da) |
| PT (1) | PT3212182T (da) |
| RS (1) | RS59240B1 (da) |
| RU (1) | RU2712211C2 (da) |
| WO (1) | WO2016066172A1 (da) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2743223T3 (es) * | 2014-10-27 | 2020-02-18 | Pharmacosmos Holding As | Tratamiento o prevención de la anemia en mamíferos no humanos gestantes y crías |
| EP3479118A4 (en) * | 2016-06-30 | 2020-01-15 | NDSU Research Foundation | METHOD FOR IMPROVING THE QUALITY AND QUANTITY OF BOYS IN MAMMALS |
| BR112020004357A2 (pt) | 2017-09-11 | 2020-09-08 | Pharmacosmos Holding A/S | compostos de complexo de ferro para uso terapêutico |
| EP3473268A1 (en) * | 2017-10-20 | 2019-04-24 | IDT Biologika GmbH | Combined preparation for parenteral use |
| WO2020089227A1 (en) | 2018-10-29 | 2020-05-07 | Pharmacosmos Holding A/S | Treating iron deficiency with ferric carboxymaltose |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3105791A (en) | 1961-07-20 | 1963-10-01 | Richardson Merrell Inc | Method of preventing the development of iron deficiency anemia in suckling pigs |
| US3259500A (en) * | 1961-10-11 | 1966-07-05 | Kentucky Res Foundation | Method for inhibiting anemia in young pigs by feeding the sow an iron agent |
| US4076803A (en) | 1976-03-15 | 1978-02-28 | Ashmead H H | Synergistic combination of metal proteinates with beta-chlorovinyl dialkyl phosphates |
| DK172860B1 (da) * | 1998-03-25 | 1999-08-16 | Pharmacosmos Holding As | Jerndextranforbindelse til anvendelse som komponent i et terapeutisk middel til forebyggelse af eller behandling af jernman |
| WO2002085134A1 (en) * | 2001-04-24 | 2002-10-31 | Lonza Ltd. | Method of enhancing reproductive performance in sows |
| RU2274003C2 (ru) | 2004-03-02 | 2006-04-20 | Станислав Людвигович Люблинский | Способ комплексной переработки крови сельскохозяйственных животных для получения биологически активного вещества с противоанемическими свойствами на основе гемоглобина, биологически активное вещество с противоанемическими свойствами (варианты) и продукт, его содержащий (варианты). |
| DE102007054794A1 (de) | 2007-11-13 | 2009-05-14 | Agilan Gmbh | Wässrige Eisen-Dextran-Zubereitung mit ein oder mehreren Verbindungen der para-Hydroxy-Benzoesäureester und/oder deren Salzen |
| NZ595597A (en) * | 2009-03-25 | 2013-05-31 | Pharmacosmos Holding As | A stable iron oligosaccharide compound |
| MY186535A (en) | 2011-02-17 | 2021-07-26 | Boehringer Ingelheim Vetmedica Gmbh | Novel european prrsv strain |
| ES2743223T3 (es) * | 2014-10-27 | 2020-02-18 | Pharmacosmos Holding As | Tratamiento o prevención de la anemia en mamíferos no humanos gestantes y crías |
-
2015
- 2015-10-27 ES ES15787128T patent/ES2743223T3/es active Active
- 2015-10-27 CN CN202110410139.3A patent/CN113559115A/zh active Pending
- 2015-10-27 DK DK15787128.6T patent/DK3212182T3/da active
- 2015-10-27 RU RU2017118319A patent/RU2712211C2/ru active
- 2015-10-27 LT LTEP15787128.6T patent/LT3212182T/lt unknown
- 2015-10-27 PT PT15787128T patent/PT3212182T/pt unknown
- 2015-10-27 BR BR112017008709A patent/BR112017008709A2/pt not_active Application Discontinuation
- 2015-10-27 WO PCT/DK2015/050328 patent/WO2016066172A1/en active Application Filing
- 2015-10-27 MX MX2017005419A patent/MX2017005419A/es active IP Right Grant
- 2015-10-27 JP JP2017522471A patent/JP6680777B2/ja active Active
- 2015-10-27 CN CN201580058214.7A patent/CN107206017B/zh not_active Expired - Fee Related
- 2015-10-27 PL PL15787128T patent/PL3212182T3/pl unknown
- 2015-10-27 CA CA2965722A patent/CA2965722C/en active Active
- 2015-10-27 HU HUE15787128A patent/HUE045092T2/hu unknown
- 2015-10-27 RS RSP20190966 patent/RS59240B1/sr unknown
- 2015-10-27 EP EP19181718.8A patent/EP3603632A1/en not_active Withdrawn
- 2015-10-27 EP EP15787128.6A patent/EP3212182B1/en active Active
- 2015-10-27 US US15/522,466 patent/US11040059B2/en active Active
- 2015-10-27 CN CN202110407403.8A patent/CN113476471A/zh active Pending
-
2017
- 2017-04-06 PH PH12017500646A patent/PH12017500646A1/en unknown
-
2021
- 2021-03-15 US US17/201,110 patent/US20210369763A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP3603632A1 (en) | 2020-02-05 |
| US11040059B2 (en) | 2021-06-22 |
| RU2017118319A (ru) | 2018-11-29 |
| LT3212182T (lt) | 2019-10-10 |
| CN107206017B (zh) | 2021-05-07 |
| EP3212182A1 (en) | 2017-09-06 |
| CN113476471A (zh) | 2021-10-08 |
| RU2017118319A3 (da) | 2019-06-17 |
| CA2965722A1 (en) | 2016-05-06 |
| WO2016066172A1 (en) | 2016-05-06 |
| JP2017535537A (ja) | 2017-11-30 |
| CN107206017A (zh) | 2017-09-26 |
| ES2743223T3 (es) | 2020-02-18 |
| US20170333470A1 (en) | 2017-11-23 |
| BR112017008709A2 (pt) | 2017-12-26 |
| PH12017500646A1 (en) | 2017-09-25 |
| HUE045092T2 (hu) | 2019-12-30 |
| CA2965722C (en) | 2023-02-14 |
| PT3212182T (pt) | 2019-07-29 |
| US20210369763A1 (en) | 2021-12-02 |
| JP6680777B2 (ja) | 2020-04-15 |
| CN113559115A (zh) | 2021-10-29 |
| RS59240B1 (sr) | 2019-10-31 |
| MX2017005419A (es) | 2017-11-30 |
| RU2712211C2 (ru) | 2020-01-27 |
| PL3212182T3 (pl) | 2019-12-31 |
| EP3212182B1 (en) | 2019-06-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3368534T3 (da) | Valbenazin-ditosylat og polymorfer deraf | |
| DK3380101T3 (da) | Eif4-a-inhiberende forbindelser og fremgangsmåder relateret dertil | |
| DK3129018T3 (da) | Behandling af NAFLD og NASH | |
| DK3234133T3 (da) | Crispr-baserede sammensætninger og fremgangsmåder til anvendelse | |
| DK3102673T3 (da) | Fremgangsmåder og sammensætninger til behandling af beta-talassæmi | |
| DK3149019T3 (da) | Cholan-derivater til anvendelse ved behandling og/eller forebyggelse af FXR- og TGR5/GPBAR1-formidlede sygdomme | |
| DK3155024T3 (da) | Opholdsstrukturer og relaterede fremgangsmåder | |
| DK3693158T3 (da) | Asymmetrisk forarbejdningsfremgangsmåde til krumningsreduktion i laminatstrukturer | |
| DK3206686T3 (da) | Gamma-diketoner til behandling og forebyggelse af ældning af huden og rynker | |
| SG11201608179PA (en) | Fast viscoacoustic and viscoelastic full-wavefield inversion | |
| DK3218358T3 (da) | Ifluorometyl-aminopyridiner og difluorometyl-aminopyrimidiner | |
| DK3209696T3 (da) | Fremgangsmåder og sammensætninger til diagnosticering og behandling af glioblastom | |
| DK3366307T3 (da) | Sammensætninger og fremgangsmåder til inhibering af masp-1 og/eller masp-3 til behandling af paroxystisk nokturn hæmoglobinuri | |
| DK3194564T3 (da) | Trichodermasammensætninger og anvendelsesfremgangsmåder | |
| DK3189074T3 (da) | Sammensætninger og metoder til behandling og forebyggelse af inflammation | |
| ITUB20156293A1 (it) | Circuito integrato con trincea isolata e relativi metodi | |
| DK3265641T3 (da) | Stigørenhed og fremgangsmåde | |
| DK3019167T3 (da) | Behandling af forhøjede niveauer af eosinophiler og/eller basophiler | |
| DK3384079T3 (da) | Fibrøs konstruktion og fremgangsmåder i forbindelse hermed | |
| DK3212776T3 (da) | Sammensætninger og fremgangsmåder i forbindelse med beta-glucosidase | |
| DK3217963T3 (da) | Fremgangsmåder til behandling af individer med prader-willis syndrom eller smith-magenis syndrom | |
| DK2961420T3 (da) | Fremgangsmåder og sammensætninger til forebyggelsen eller behandlingen af barth syndrom | |
| DK3191103T3 (da) | Sammensætninger og fremgangsmåder til behandling af præcancerøse hudlæsioner | |
| DK3107902T3 (da) | Forbindelser og fremgangsmåder til at hæmme fascin | |
| DK3212182T3 (da) | Behandling eller forebyggelse af anæmi i drægtige ikke-humane pattedyr og afkom |